Martin Shkreli barred from drug industry and fined $64.6m by US court - The Guardian

Friday ruling came after FTC and seven states brought a case against Shkreli, nicknamed the ‘Pharma Bro’.

The Friday ruling came after the Federal Trade Commission (FTC) and seven states brought a case against Shkreli, nicknamed the “Pharma Bro” for his sometimes outrageous behavior.

In 2018 in an unrelated case, Shkreli was jailed for seven years for securities fraud.

The New York state attorney general, Letitia James, brought the case against Shkreli in January 2020, accusing him of using monopoly control to keep the drug price high.